Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy

Rheumatol Int. 2009 Nov;30(1):39-43. doi: 10.1007/s00296-009-0895-6.

Abstract

Mutations in HPGD have recently been reported to cause primary hypertrophic osteoarthropathy (PHO), a rare genetic disease characterized by digital clubbing, pachydermia, and periostosis. We screened HPGD mutations in six patients from three unrelated Turkish families with PHO, in which we showed one previously reported, p.A140P, and one novel, p.M1L, homozygous mutations. Both mutations co-segregated with the phenotype in all three families and were absent in 100 Turkish controls. These results confirm the presence of biallelic HPGD mutations in patients with PHO in an independent series from a different population.

MeSH terms

  • Adolescent
  • Adult
  • Base Sequence
  • Case-Control Studies
  • Child
  • DNA Mutational Analysis
  • Female
  • Genetic Predisposition to Disease
  • Heredity
  • Homozygote*
  • Humans
  • Hydroxyprostaglandin Dehydrogenases / genetics*
  • Male
  • Molecular Sequence Data
  • Mutation*
  • Osteoarthropathy, Primary Hypertrophic / enzymology
  • Osteoarthropathy, Primary Hypertrophic / genetics*
  • Pedigree
  • Phenotype
  • Turkey
  • Young Adult

Substances

  • Hydroxyprostaglandin Dehydrogenases
  • 15-hydroxyprostaglandin dehydrogenase